Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 4 2Phase 3 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Conditions

Neoplasms 2Venous Thrombosis 1Thromboembolism 1

Interventions

Dexamethasone 8Oxycodone 6Epoetin Alfa 5Propofol 4Palonosetron 4Meropenem 4Zoledronic Acid 3Vancomycin 3Sevoflurane 3Ondansetron 3Naloxone 3Everolimus 3Ciprofloxacin 3Cholecalciferol 3Ceftazidime 3Cefepime 3Calcium Dobesilate 3Bevacizumab 3Aspirin 3Aprepitant 3peginterferon alfa-2a 2edoxaban 2apixaban 2apatinib 2Vitamin B 12 2Vincristine 2Tobacco Use Cessation Devices 2Teicoplanin 2Tablets 2Surgical Procedures, Operative 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × Neoplasms × edoxaban × Clear all
NCT03895502 2023-10-04

ONCO DVT

Kyoto University, Graduate School of Medicine

Phase 4 Completed
605 enrolled

Neoplasms, Venous Thrombosis

NCT04072068 2023-05-30

EDOI

Gruppo Oncologico Italiano di Ricerca Clinica

Phase 4 Completed
150 enrolled

Neoplasms, Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡